Patent classifications
A61M1/3666
Adjustable shunt pediatric/neonatal ECMO circuit
Embodiments of the present invention provide an extra corporeal membrane oxygenation circuit, wherein a pump communicates blood from a patient to an oxygenator and thence back to the patient, comprising: (a) a medium diameter venous line configured to accept blood from the patient and communicate the blood to the pump; (b) a medium diameter arterial line configured to accept blood from the oxygenator and communicate the blood to the patient; (c) one or more shunts connected in a series, where each shunt comprises a medium diameter input connected to a medium diameter output, where the medium diameter output is configured to connect to a medium diameter input of a successive shunt; a small diameter outlet between the medium diameter input and the medium diameter output; and a stopcock connected to the small diameter output such that flow out of the small diameter outlet can be controlled by the stopcock; wherein a first of such shunts is connected to accept blood from the venous line in parallel with the pump and wherein a last of such shunts is connected to communicate blood to the arterial line.
BLOOD PROCESSING UNIT WITH MODIFIED FLOW PATH
A blood processing apparatus may include a heat exchanger and a gas exchanger. At least one of the heat exchanger and the gas exchanger may be configured to impart a radial component to blow flow through the heat exchanger and/or gas exchanger. The heat exchanger may be configured to cause blood flow to follow a spiral flow path.
BLOOD CIRCULATION SYSTEM
A blood circulation system that can be connected to a human body is provided. The system may include a roller pump, a blood removal line through which blood removed from the human body flows to the roller pump, a blood transfer line that transfers blood, which is sent from the roller pump, to the human body, means for measuring a blood removal rate provided in the blood removal line to measure a blood removal rate parameter of blood flowing through the blood removal line and a control unit, wherein the control unit is programmed to control a blood transfer rate of the roller pump by controlling a rotational speed of the roller pump with a control signal, such that a transfer rate of blood flowing through the blood transfer line is synchronized with a removal rate calculated from the blood removal rate parameter.
HEART LUNG MACHINE HAVING CONTROL ASSEMBLY WITH SPACE-SAVING DISPLAY FEATURES
Embodiments of the subject matter include a heart lung machine (HLM), including a plurality of actuators and a peripheral processing unit configured to receive a set of parameter data from the plurality of actuators. The HLM also may include a peripheral display device configured to present a subset of the set of parameter data and a control assembly comprising a control display device configured to present a user interface having a representation of a parameter value and an associated indication, where at least a portion of the associated indication overlaps at least a portion of the representation of the parameter value.
HLM PUMP STOP REACTION
A heart lung machine (HLM) includes: a pump actuator; an actuator control unit (ACU) operably connected to the pump actuator; a processing unit configured to receive a set of parameter data from the actuator; a display device configured to present a subset of the set of parameter data; and an input control device operably connected to the pump actuator. The input control device includes a rotatable knob. The ACU may be configured to: determine that the pump actuator has been stopped in response to a pump-stop trigger event; determine that the rotatable knob has been rotated to a first position; and in response to determining that the rotatable knob has been rotated to the first position, starting the pump actuator.
Blood processing unit with modified flow path
A blood processing apparatus may include a heat exchanger and a gas exchanger. At least one of the heat exchanger and the gas exchanger may be configured to impart a radial component to blow flow through the heat exchanger and/or gas exchanger. The heat exchanger may be configured to cause blood flow to follow a spiral flow path.
DEVICE AND METHOD FOR DETERMINATION OF A CO2 PARTIAL PRESSURE VALUE ON A BLOOD SIDE OF AN OXYGENATOR
Device for determination of a CO2 partial pressure value on a blood side of an oxygenator having an oxygenator with a blood side, a gas side and a semipermeable membrane, wherein the membrane separates the blood side from the gas side, the gas side has an inlet and an outlet and, during operation of the oxygenator, a gas flow flows into the inlet to the outlet at a flow rate. The device also has a first sensor configured to measure CO2 partial pressure values of the gas side and a control unit configured to process the measured CO2 partial pressure values of the gas side and to determine a CO2 partial pressure value on the blood side based on the measured CO2 partial pressure values of the gas side. The control unit determines the CO2 partial pressure value on the blood side during operation of the oxygenator.
UNIVERSAL HOLDER SYSTEM
A holder system capable of mounting at least one medical device component to a control console support includes a triplex holder arm configured to connect to and support at least one medical device component; a receiver or receiver arm assembly configured to connect to the triplex holder arm, wherein the receiver is attached to the control console support to mount the triplex holder arm and the at least one medical device component on the control console support; and a locking assembly configured to releasably connect the triplex holder arm to the receiver or receiver arm assembly.
COMPOSITIONS AND METHODS FOR REDUCING CELL-FREE DNA
This invention relates to compositions and methods for treating subjects in need of mechanical support, such as those who have had surgery and/or are in need of pro-inflammatory reduction. The mechanical support can comprise a filter that reduces the amount of cell-free DNA in the subject, in some embodiments. The subject may be treated with cf-DNA inhibitors in other embodiments.
SYSTEMS, DEVICES, AND METHODS FOR EXTRACORPOREAL REMOVAL OF CARBON DIOXIDE
Systems, devices, and methods are provided for removing carbon dioxide from a target fluid, such as, for example, blood, to treat hypercarbic respiratory failure or another condition. A device is provided including first and second membrane components for removing dissolved gaseous carbon dioxide and bicarbonate from the fluid, which can be done simultaneously. The device can be in the form of a cartridge configured for use in a dialysis system. A method of treatment is also provided, involving drawing blood from a patient and bringing the patient’s blood in contact with a first membrane component having a sweep gas passing therethrough, and a second membrane component having a dialysate passing therethrough. The dialysate’s composition can be selected such that charge neutrality is maintained.